VIVS Stock Analysis: Buy, Sell, or Hold?
VIVS - VivoSim Labs, Inc. Common Stock
$0.47
0.14 (41.86%)
â˛
5d:
+35.81%
30d:
-41.59%
90d:
-66.81%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 11, 2026
2d
Get Alerted When VIVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: VIVS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: VIVS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: VIVS is currently trading at $0.47, which is considered slightly low relative to its 30-day fair value range of $0.37 to $0.89.
Technical Outlook: Technically, VIVS is in a strong downtrend. Immediate support is located at $0.31, while resistance sits at $0.58. The stock is showing strong short-term momentum, up 41.9% recently.
Market Sentiment: VIVS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VIVS is in a strong downtrend. Immediate support is located at $0.31, while resistance sits at $0.58. The stock is showing strong short-term momentum, up 41.9% recently.
Market Sentiment: VIVS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.37 -
$0.89
Company Quality Score
52/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
94.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+41.9%)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.37 -
$0.89
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.31
Resistance Level
$0.58
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Revenue Growth (YoY)
-21.6%
Share & Embed Analysis
Last updated: August 08, 2026 5:25 AM ET
Data refreshes hourly during market hours. Next update: 6:25 AM
Data refreshes hourly during market hours. Next update: 6:25 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VIVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 56 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 51 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 47 HOLD |
